Do melanoma-spotting apps have a place in clinical care?
Melanoma-spotting smartphone apps have been burned regularly by researchers, who claim their poor specificity can leave patients falsely reassured about dangerous lesions.
Researchers' latest look at whether the technology has a genuine place in clinical care is a systemic review of the evidence.
Nine studies were included, evaluating a total of six apps.
Published in the BMJ, the general conclusion of the review was blunt: the performance of the technology was “poor and variable”.